Related references
Note: Only part of the references are listed.
Article
Urology & Nephrology
Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis
Peggy Perrin et al.
KIDNEY INTERNATIONAL REPORTS (2022)
Article
Transplantation
Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study
Rikako Hiramatsu et al.
Summary: The study revealed that hemodialysis patients may experience acute hypocalcemia following denosumab injection. High bone turnover was identified as an independent risk factor for the calcium declines induced by denosumab. Denosumab significantly increased bone mineral density at the lumbar spine and femoral neck after 24 months.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Article
Endocrinology & Metabolism
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Share Paper
